NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
WednesdayDec 05, 2018 11:30 am

NeuroMetrix, Inc. (NURO) Starts Presentation at LD Micro Main Event

NeuroMetrix (NASDAQ: NURO) is a commercial-stage, innovation-driven healthcare company uniting neurostimulation and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The company’s two main products are Quell, an over-the-counter wearable therapeutic device for chronic pain, and DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more information, visit www.NeuroMetrix.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective…

Continue Reading

WednesdayDec 05, 2018 11:30 am

Piedmont Lithium (PLLL) Starts Presentation at LD Micro Main Event

Piedmont Lithium (NASDAQ: PLLL) is an emerging lithium company focused on the development of its 100%-owned Piedmont Lithium Project in North Carolina, with the goal of becoming a strategic domestic supplier of lithium to the increasing electric vehicle and battery storage markets in the U.S. The Piedmont Lithium Project is located in one of the premier regions in the world for lithium exploration, given its favorable geology and ideal location with easy access to infrastructure, power, R&D centers for lithium and battery storage and major high-tech population centers. For more information, visit the company's website at www.piedmontlithium.com. About NetworkNewsWire NetworkNewsWire…

Continue Reading

WednesdayDec 05, 2018 11:30 am

Artelo Biosciences, Inc. (ARTL) Starts Presentation at LD Micro Main Event

Artelo Biosciences, Inc. (OTC: ARTL) is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system.  Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies. For more information, visit the company's website at www.artelobio.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that…

Continue Reading

WednesdayDec 05, 2018 11:30 am

Nano One Materials Corp. (TSX.V: NNO) (NNOMF) Starts Presentation at LD Micro Main Event

Nano One Materials Corp. (NNO.V) (NASDAQ: NNOMF) is developing patented technology for the low-cost production of high-performance battery materials used in electric vehicles, energy storage, consumer electronics and next generation batteries. The processing technology addresses fundamental supply chain constraints by enabling wider raw materials specifications for use in lithium ion batteries. The process can be configured for a range of different nanostructured materials and has the flexibility to shift with emerging and future battery market trends. Nano One’s mission is to establish its patented technology as a leading platform for the global production of a new generation of nanostructured composite…

Continue Reading

WednesdayDec 05, 2018 11:30 am

Profire Energy, Inc. (PFIE) Starts Presentation at LD Micro Main Event

Profire Energy, Inc. (NASDAQ: PFIE) assists energy production companies in the safe and efficient production and transportation of oil and natural gas. As energy companies seek greater safety for their employees, compliance with more stringent regulatory standards, and enhanced margins with their energy production processes, Profire Energy's burner management and chemical injection systems are increasingly becoming part of their solution. Profire Energy has offices in Lindon, Utah; Victoria, Texas; Homer, Pennsylvania; Greeley, Colorado; and Edmonton, Alberta, Canada. For more information, visit the company's website at www.ProfireEnergy.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides…

Continue Reading

WednesdayDec 05, 2018 11:00 am

Quest Resource Holding Corporation (QRHC) Starts Presentation at LD Micro Main Event

Quest Resource (NASDAQ: QRHC) is a national provider of reuse, recycling, and disposal services that enable its customers to achieve and satisfy environmental and sustainability goals and responsibilities.  Quest provides businesses across multiple industry sectors with single source solutions for the reuse, recycling, and disposal of a wide variety of waste streams and recyclables generated by their operations.  Quest’s customers typically are multi-location businesses for which the company creates, implements, and manages customer-specific programs for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. For more information, visit the company's website at www.QRHC.com About NetworkNewsWire NetworkNewsWire (NNW)…

Continue Reading

WednesdayDec 05, 2018 11:00 am

Tonix Pharmaceuticals Holding Corp. (TNXP) Starts Presentation at LD Micro Main Event

Tonix Pharmaceuticals (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmaceutical products to treat serious neuropsychiatric conditions and focused on improving biodefense through developing potential medical counter-measures. The company is currently developing Tonmya as a bedtime treatment for PTSD. Tonmya is in phase 3 development and has been granted Breakthrough Therapy designation. Additionally, TNXP is developing TNX-102 SL as a bedtime treatment for agitation in Alzheimer’s disease under a separate IND to support a phase 2, potential pivotal, efficacy study for this indication. The company has been designated a Fast Track development program by…

Continue Reading

WednesdayDec 05, 2018 11:00 am

Biocept, Inc. (BIOC) Starts Presentation at LD Micro Main Event

Biocept, Inc. (NASDAQ: BIOC) is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma.  Biocept uses its proprietary liquid biopsy technology to provide physicians with information for treating and monitoring patients diagnosed with cancer. The company's patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in plasma (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. For more information, visit the company's…

Continue Reading

WednesdayDec 05, 2018 11:00 am

GreenPower Motor Co., Inc. (GPVRF) (TSX.V: GPV) Starts Presentation at LD Micro Main Event

GreenPower Motor Company, Inc. (TSXV: GPV) (OTCQX: GPVRF) designs, builds and distributes a full suite of high-floor and low-floor vehicles, including transit buses, school buses, shuttles, and a double decker. GreenPower employs a clean-sheet design to manufacture all-electric buses that are purpose built to be battery powered with zero emissions. GreenPower integrates global suppliers for key components, such as Siemens or TM4 for drive motors, Knorr for brakes, ZF for axles and Parker for dash and contro l systems. This OEM platform allows GreenPower to meet specifications of various operators while providing standard parts for ease of maintenance and accessibility…

Continue Reading

WednesdayDec 05, 2018 11:00 am

BioTime, Inc. (BTX) Starts Presentation at LD Micro Main Event

BioTime, Inc. (NYSE: BTX) is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime’s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime’s lead cell replacement product candidate is OpRegen, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime’s lead cell delivery clinical program is Renevia, an investigational medical device being developed as an alternative for whole adipose tissue transfer procedures. For more information,…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

NetworkNewsWire is powered by IBNAi

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers